Osel Sees Immunotherapy-Like Trajectory For Oncology Microbiome Candidate

 
• By Alaric DeArment
  
Bacterias 3D rendering
Osel announced results of a Phase I trial combining its microbiome therapy with BMS's Opdivo • Source: Shutterstock

More from Anticancer

More from Therapy Areas